RU2003119140A - Эмульсионный препарат - Google Patents
Эмульсионный препарат Download PDFInfo
- Publication number
- RU2003119140A RU2003119140A RU2003119140/15A RU2003119140A RU2003119140A RU 2003119140 A RU2003119140 A RU 2003119140A RU 2003119140/15 A RU2003119140/15 A RU 2003119140/15A RU 2003119140 A RU2003119140 A RU 2003119140A RU 2003119140 A RU2003119140 A RU 2003119140A
- Authority
- RU
- Russia
- Prior art keywords
- phosphatidylethanolamine
- phosphatidylcholine
- emulsion preparation
- ratio
- preparation according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (7)
1. Эмульсионный препарат, имеющий величину рН от 6 до 8, содержащий эбселен, жир и масло, фосфатидилхолин и фосфатидилэтаноламин.
2. Эмульсионный препарат по п.1, в котором величина рН составляет от 6,5 до 7,5.
3. Эмульсионный препарат по любому из пп.1-2, в котором соотношение фосфатидилэтаноламина и фосфатидилхолина, т.е. отношение фосфатидилэтаноламин:фосфатидилхолин составляет от 0,1:99,9 до 10:90 (массовое соотношение).
4. Эмульсионный препарат по любому из пп.1-2, в котором соотношение фосфатидилэтаноламина и фосфатидилхолина, т.е. отношение фосфатидилэтаноламин:фосфатидилхолин составляет от 0,1:99,9 до 5:95 (массовое соотношение).
5. Эмульсионный препарат по любому из пп.1-4, в котором жир и масло представляют собой триглицериды.
6. Эмульсионный препарат по любому из пп.1-4, в котором жир и масло представляют собой соевое масло.
7. Эмульсионный препарат по любому из пп.1-6, в котором препарат представляет собой стерильный препарат.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-400130 | 2000-12-28 | ||
| JP2000400130 | 2000-12-28 | ||
| JP2001-13160 | 2001-01-22 | ||
| JP2001013160 | 2001-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2003119140A true RU2003119140A (ru) | 2004-12-27 |
Family
ID=26607000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003119140/15A RU2003119140A (ru) | 2000-12-28 | 2001-12-17 | Эмульсионный препарат |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1356814A4 (ru) |
| JP (1) | JPWO2002053154A1 (ru) |
| KR (1) | KR20030069196A (ru) |
| CA (1) | CA2432136A1 (ru) |
| NO (1) | NO20032957L (ru) |
| RU (1) | RU2003119140A (ru) |
| WO (1) | WO2002053154A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1174423A4 (en) | 1999-03-31 | 2008-03-19 | Arne Holmgren | SUBSTRATES FOR THIOREDOXINE REDUCTASE |
| US8557861B2 (en) | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| JP4886233B2 (ja) * | 2005-07-21 | 2012-02-29 | 独立行政法人物質・材料研究機構 | エブセレンの可溶化方法 |
| US20080293777A1 (en) * | 2007-05-23 | 2008-11-27 | Erlanson Daniel A | Weight Loss Treatment |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| US20190038555A1 (en) * | 2016-02-26 | 2019-02-07 | The Regents Of The University Of California | Bicontinuous microemulsions and methods of use thereof |
| JP7608086B2 (ja) * | 2020-07-31 | 2025-01-06 | 東和薬品株式会社 | シームレスカプセル |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3620674A1 (de) * | 1986-06-20 | 1987-12-23 | Nattermann A & Cie | Salbe zur behandlung von hauterkrankungen |
| DE3836892A1 (de) * | 1988-10-29 | 1990-05-03 | Nattermann A & Cie | Parenteral applizierbare, stabile arzneimittelloesungen |
| DE59310166D1 (de) * | 1992-05-18 | 2001-05-31 | Ciclomulsion Ag | Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung |
| EP0656779B1 (en) * | 1992-08-28 | 2000-04-12 | Pharmos Corporation | Submicron emulsions as ocular drug delivery vehicles |
| EP0604806A3 (de) * | 1992-12-18 | 2000-07-19 | Rhone-Poulenc Rorer Gmbh | Phospholipidische Zusammensetzung |
-
2001
- 2001-12-17 CA CA002432136A patent/CA2432136A1/en not_active Abandoned
- 2001-12-17 KR KR10-2003-7008588A patent/KR20030069196A/ko not_active Withdrawn
- 2001-12-17 RU RU2003119140/15A patent/RU2003119140A/ru not_active Application Discontinuation
- 2001-12-17 EP EP01272815A patent/EP1356814A4/en not_active Withdrawn
- 2001-12-17 WO PCT/JP2001/011047 patent/WO2002053154A1/ja not_active Ceased
- 2001-12-17 JP JP2002554104A patent/JPWO2002053154A1/ja active Pending
-
2003
- 2003-06-26 NO NO20032957A patent/NO20032957L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002053154A1 (en) | 2002-07-11 |
| EP1356814A4 (en) | 2004-04-07 |
| NO20032957L (no) | 2003-08-28 |
| EP1356814A1 (en) | 2003-10-29 |
| NO20032957D0 (no) | 2003-06-26 |
| JPWO2002053154A1 (ja) | 2004-04-30 |
| CA2432136A1 (en) | 2002-07-11 |
| KR20030069196A (ko) | 2003-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE117547T1 (de) | Orale lipidarzneiform. | |
| FR14C0080I2 (fr) | Methode d'administration d'un anticorps | |
| DZ3432A1 (fr) | Formulation d'insecticides en emulsion de type huileux | |
| DE60104206D1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
| ATE281085T1 (de) | Nahrungsergänzung zur behandlung von makula degeneration | |
| RU2003119140A (ru) | Эмульсионный препарат | |
| DE50107978D1 (de) | Salze von L-Aminosäuren mit verbessertem Geschmack und ihre Herstellung | |
| BRPI0214562B8 (pt) | metassilicato de cálcio, preparação farmacêutica veterinária, produto alimentício, de cuidado com a casa, farmacêutico, agrícola, cosmético e método para formar um metassilicato de cálcio desidratado | |
| EA200300597A1 (ru) | Бифенилкарбоксамиды, полезные в качестве снижающих содержание липидов агентов | |
| RU2004124063A (ru) | Сигарета и сигаретный фильтр | |
| ATE125541T1 (de) | Reine kristalline form von rifapentin. | |
| RU97106023A (ru) | Суппозитории ректальные для лечения заболеваний в педиатрии | |
| EA200100269A1 (ru) | Иммуногенные липосомные композиции | |
| RU97120919A (ru) | Средство для лечения ожогов | |
| RU2003114829A (ru) | Гинекологические овули с дибунолом для лечения воспалительных заболеваний | |
| RU93003792A (ru) | Препарат для лечения заболеваний желудка, связанных с секреторной недостаточностью, на основе куриного пепсина | |
| JP2003137805A5 (ja) | 血清脂質低下剤および健康食品 | |
| RU98105696A (ru) | Средство для лечения и профилактики болезней полости рта | |
| RU2000110437A (ru) | Препарат для лечения желудочно-кишечных заболеваний у свиней | |
| RU98105172A (ru) | Свечи, обладающие противовоспалительным и ранозаживляющим действием | |
| ATE548441T1 (de) | Cholesterin senkende strukturierte lipide mit omega 3 pufa | |
| RU2001135700A (ru) | Пищевой масложировой функциональный продукт | |
| JP3008883U (ja) | サイズ調節パッキン付靴の中敷 | |
| RU2001117146A (ru) | Ранозаживляющие суппозитории | |
| FR2820425B1 (fr) | Melange de peptides issus d'une proteine nef et leurs applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20011217 |